🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New Phase 3 readout shows #antibody therapy #Uplizna can be useful for another #immunedisorder: generalized myasthenia gravis (gMG). Uplizna is based on tech licensed from Duke University, developed by the late Dr. Thomas Tedder (Duke University School of Medicine) and colleagues. otc.duke.edu/news/amgen-pre…

Welcome to the 2024-25 cohort of the Duke OTC OTC Fellows! These grad students and postdocs gain hands-on experience helping evaluate and market real #technology and #IP coming out of Duke University. Learn more at: otc.duke.edu/otc-fellows-pr…

The RFA for DIHI closes soon! Faculty, staff, students, and trainees across Duke University and Duke Health encouraged to apply. $25-60K for a year's support of healthcare innovation projects. dihi.org/rfa

Great story on Humacyte from the The Wall Street Journal! Humacyte is a Duke University startup out of the lab of Dr. Laura Niklason (formerly Anesthesiology, Duke University School of Medicine), cofounded with Drs. Juliana Blum & Shannon Dahl. #innovation #healthcare #university #techtransfer #startup wsj.com/health/healthc…

Learn about the new #AI powered #research tool Inquisite developed by Jon Reifschneider, Pramod Singh and team from Duke Engineering otc.duke.edu/news/new-ai-pr…

When we're talking about the #startup community here in the Triangle – Duke University, UNC-Chapel Hill, NC State University all get along and partner with NCBiotech #NCLifeSciences to showcase promising #medtech innovations growing in the area. Learn more about our recent Triangle Venture Day: otc.duke.edu/news/early-sta…

Don't miss out on this fun Duke I&E #Duke100 event, featuring Duke Capital Partners portco Vestwell CEO Aaron Schumm. A week from today! #entrepreneurship #innovation #startup #pitching RSVP: rsvp.duke.edu/event/c92b4838…

We're #hiring! Duke OTC is looking for another #LifeSciences #licensing manager with #techtransfer experience. Inquire within: careers.duke.edu/job/Durham-ASS…

Congrats to Tune Therapeutics on having the first #epigenetic therapy to enter clinical trials for an infectious disease! Tune is a Duke University spinout and Duke Capital Partners portfolio company cofounded by Duke Engineering's Charles Gersbach. otc.duke.edu/news/tune-ther…

Thanks for profiling Robin and our office Working@Duke! If you want to learn more about #innovation at Duke University, our annual free Invented at Duke event is this Wednesday! otc.duke.edu/event/invented…